Compared to Estimates, United Therapeutics (UTHR) Q4 Earnings: A Look at Key Metrics

For the quarter ended December 2025, United Therapeutics (UTHR) reported revenue of $790.2 million, up 7.4% over the same period last year. EPS came in at $7.70, compared to $6.19 in the year-ago quarter.The reported revenue represents a surprise of -1.88% over the Zacks Consensus Estimate of $805.31 million. With the consensus EPS estimate being $6.78, the EPS surprise was +13.5%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall ...